0001562180-21-002171.txt : 20210311 0001562180-21-002171.hdr.sgml : 20210311 20210311144853 ACCESSION NUMBER: 0001562180-21-002171 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210309 FILED AS OF DATE: 20210311 DATE AS OF CHANGE: 20210311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hill, Mitch C. CENTRAL INDEX KEY: 0001644989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39293 FILM NUMBER: 21732927 MAIL ADDRESS: STREET 1: 1009 TENNYSON DRIVE CITY: SOUTHLAKE STATE: TX ZIP: 76902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inari Medical, Inc. CENTRAL INDEX KEY: 0001531048 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 452902923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 PARKER, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-923-4747 MAIL ADDRESS: STREET 1: 9 PARKER, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: Inceptus Newco1 Inc. DATE OF NAME CHANGE: 20110923 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-03-09 false 0001531048 Inari Medical, Inc. NARI 0001644989 Hill, Mitch C. C/O INARI MEDICAL, INC. 9 PARKER, SUITE 100 IRVINE CA 92618 false true false false Chief Financial Officer Common Stock 2021-03-09 4 M false 5000.00 0.457 A 73190.00 D Common Stock 2021-03-09 4 S false 100.00 94.05 D 73090.00 D Common Stock 2021-03-09 4 S false 400.00 95.5275 D 72690.00 D Common Stock 2021-03-09 4 S false 1500.00 97.444 D 71190.00 D Common Stock 2021-03-09 4 S false 2058.00 98.3925 D 69132.00 D Common Stock 2021-03-09 4 S false 942.00 99.2801 D 68190.00 D Common Stock 1600.00 I By Spouse Stock Options (Right to buy) 0.457 2021-03-09 4 M false 5000.00 0.00 D 2029-04-30 Common Stock 5000.00 311977.00 D Includes 347 shares acquired under the Employee Stock Purchase Plan. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020 This transaction was executed in multiple trades at prices ranging from $95.25 to $95.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $96.90 to $97.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $97.91 to $98.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $98.93 to $99.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Option vested with respect to 25% of the underlying shares on April 30, 2020 and vests with respect to the remaining shares in 36 equal monthly installment thereafter. /s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill 2021-03-11